Telmisartan Reduces Axon Degeneration in Mice With Experimental Glaucoma.

Invest Ophthalmol Vis Sci · 2020 · PMC7405778 · PMID 32460313

Europe PMC DOI

hedged sentence

0.0200

closest p · 0.4× alpha

0.0200

boldest claim

The sentences

did not reach statistical significanceP = 0.02actually significant

The difference between IOP of injected eyes and their contralateral controls averaged over the course of the experiment was an increase of 3.8 +/− 2.81 mm Hg for vehicle-treated and 5.5 +/− 4.21 mm Hg for telmisartan-treated mice (mean +/− SD), but this difference did not reach statistical significance (except at day 14, P = 0.02, Student's t -test).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.